肿瘤学与转化医学（英文）2021，Vol.7Issue(3)：102-107,6.DOI:10.1007/s10330-020-0470-0
Future of targeted therapy for gastrointestinal cancer: Claudin 18.2
Future of targeted therapy for gastrointestinal cancer: Claudin 18.2
Qian Niu 1Jiamin Liu 1Xiaoxiao Luo 1Beibei Su 1Xianglin Yuan1
作者信息
- 1. Department of Oncology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
- 折叠
摘要
关键词
gastrointestinal cancer/claudin 18.2 (CLDN18.2)/targeted therapy/ideal monoclonal antibody 362 (IMAB362)/chimeric antigen receptor (CAR) T cells treatmentKey words
gastrointestinal cancer/claudin 18.2 (CLDN18.2)/targeted therapy/ideal monoclonal antibody 362 (IMAB362)/chimeric antigen receptor (CAR) T cells treatment引用本文复制引用
Qian Niu,Jiamin Liu,Xiaoxiao Luo,Beibei Su,Xianglin Yuan..Future of targeted therapy for gastrointestinal cancer: Claudin 18.2[J].肿瘤学与转化医学（英文）,2021,7(3):102-107,6.
